Definium Therapeutics飙升14.5%,COMPASS Pathways暴涨21.5%,GH Research跃升18.9%,Enveric Biosciences上涨6.6%,Cybin美国上市股票劲扬15.5%

美股速递
Apr 20

生物科技板块今日表现亮眼,多只精神健康领域个股出现大幅上涨。Definium Therapeutics股价强势攀升14.5%,COMPASS Pathways更实现21.5%的惊人涨幅。GH Research同期录得18.9%的可观增长,Enveric Biosciences也上涨6.6%。值得关注的是,Cybin公司的美国上市股票同样表现强劲,单日涨幅达到15.5%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10